Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women
dc.contributor.author | Antwi, E. | |
dc.contributor.author | Klipstein-Grobusch, K. | |
dc.contributor.author | Browne, J.L. | |
dc.contributor.author | Schielen, P.C. | |
dc.contributor.author | Koram, K.A. | |
dc.contributor.author | Agyepong, I.A. | |
dc.contributor.author | Grobbee, D.E. | |
dc.date.accessioned | 2019-07-09T09:53:09Z | |
dc.date.available | 2019-07-09T09:53:09Z | |
dc.date.issued | 2018-03 | |
dc.description.abstract | Background: We assessed whether adding the biomarkers Pregnancy Associated Plasma Protein-A (PAPP-A) and Placental Growth Factor (PlGF) to maternal clinical characteristics improved the prediction of a previously developed model for gestational hypertension in a cohort of Ghanaian pregnant women. Methods: This study was nested in a prospective cohort of 1010 pregnant women attending antenatal clinics in two public hospitals in Accra, Ghana. Pregnant women who were normotensive, at a gestational age at recruitment of between 8 and 13 weeks and provided a blood sample for biomarker analysis were eligible for inclusion. From serum, biomarkers PAPP-A and PlGF concentrations were measured by the AutoDELFIA immunoassay method and multiple of the median (MoM) values corrected for gestational age (PAPP-A and PlGF) and maternal weight (PAPP-A) were calculated. To obtain prediction models, these biomarkers were included with clinical predictors maternal weight, height, diastolic blood pressure, a previous history of gestational hypertension, history of hypertension in parents and parity in a logistic regression to obtain prediction models. The Area Under the Receiver Operating Characteristic Curve (AUC) was used to assess the predictive ability of the models. Results: Three hundred and seventy three women participated in this study. The area under the curve (AUC) of the model with only maternal clinical characteristics was 0.75 (0.64-0.86) and 0.89(0.73-1.00) for multiparous and primigravid women respectively. The AUCs after inclusion of both PAPP-A and PlGF were 0.82 (0.74-0.89) and 0.95 (0.87-1.00) for multiparous and primigravid women respectively. Conclusion: Adding the biomarkers PAPP-A and PlGF to maternal characteristics to a prediction model for gestational hypertension in a cohort of Ghanaian pregnant women improved predictive ability. Further research using larger sample sizes in similar settings to validate these findings is recommended. | en_US |
dc.identifier.other | DOI: 10.1186/s12978-018-0492-9 | |
dc.identifier.uri | http://ugspace.ug.edu.gh/handle/123456789/31332 | |
dc.language.iso | en | en_US |
dc.publisher | Reproductive Health | en_US |
dc.subject | Biomarkers | en_US |
dc.subject | Gestational hypertension | en_US |
dc.subject | Hypertensive disorders of pregnancy | en_US |
dc.subject | Prediction model | en_US |
dc.title | Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women.pdf
- Size:
- 726.56 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.6 KB
- Format:
- Item-specific license agreed upon to submission
- Description: